Immediate Impact
1 from Science/Nature 59 standout
Citing Papers
Advances in cancer immunotherapy: historical perspectives, current developments, and future directions
2025 Standout
Advanced disease therapeutics using engineered living drug delivery systems
2025 Standout
Works of Samuel Sarmiento being referenced
Development and Validation of a Population-Pharmacokinetic Model for Rurioctacog Alfa Pegol (Adynovate®): A Report on Behalf of the WAPPS-Hemo Investigators Ad Hoc Subgroup
2019
A phase I trial of intravenous infusion of ONYX-015 and enbrel in solid tumor patients
2007
Author Peers
| Author | Last Decade | Papers | Cites | ||||
|---|---|---|---|---|---|---|---|
| Samuel Sarmiento | 60 | 48 | 64 | 75 | 14 | 202 | |
| Wim van de Vrie | 49 | 14 | 80 | 48 | 21 | 256 | |
| Andrea Kelly | 67 | 22 | 99 | 43 | 21 | 266 | |
| Richard McCormack | 192 | 21 | 32 | 67 | 14 | 281 | |
| Brenda Fisher | 11 | 33 | 68 | 28 | 11 | 196 | |
| Leonard Mahomva | 95 | 51 | 57 | 25 | 17 | 277 | |
| Iuliana Bobanga | 76 | 22 | 115 | 52 | 16 | 282 | |
| Francesca Sanseverino | 27 | 29 | 73 | 33 | 19 | 280 | |
| Philip D. Hall | 33 | 29 | 124 | 9 | 12 | 289 | |
| Pooja Prabhakar | 66 | 19 | 134 | 26 | 18 | 258 | |
| Xiaoqing Lin | 41 | 27 | 23 | 129 | 16 | 284 |
All Works
Login with ORCID to disown or claim papers
Loading papers...